Industry News

• U.S. to provide antiviral medication to Latin America and the Caribbean for H1N1 influenza  HHS Secretary Kathleen Sebelius announced that the United States will provide 420,000 treatment courses of Tamiflu (Oseltamavir) to the Pan-American Health Organization (PAHO) to fight the novel H1N1 influenza in Latin America and the Caribbean.
  Dept. of Health & Human Services July 02, 2009  
• FDA approves Multaq to treat heart rhythm disorder  The U.S. Food and Drug Administration has approved Multaq tablets (dronedarone) to help maintain normal heart rhythms in patients with a history of atrial fibrillation or atrial flutter (heart rhythm disorders).
  FDA July 02, 2009  
• Johnson & Johnson and Elan Corporation announce definitive agreement  Johnson & Johnson and Elan Corporation announced a definitive agreement whereby Johnson & Johnson will acquire substantially all of the assets and rights of Elan related to its Alzheimer's Immunotherapy Program (AIP Program), through a newly formed company.
  Johnson & Johnson July 02, 2009  
• Beacon’s BrightSPOT offers promise of powerful and portable diagnostics  "People are always asking, 'Where is the device, where's the box that goes with it?" says Fred Mitchell, CEO of Beacon Biotechnology, on the reaction of people the first time they see the BrightSPOT System.
  RockyRadar July 01, 2009  
• Graceway Pharmaceuticals acquires early-stage dermatological molecules from Pfizer  Graceway Pharmaceuticals and Pfizer announced that they have entered into an Acquisition and License Agreement by which Graceway will acquire worldwide commercial rights for three investigational dermatological molecules from Pfizer and the related transferred or licensed intellectual properties.
  Pfizer Inc. July 01, 2009  
• Myriad Genetics announces completion of spin off  Myriad Genetics announced the successful completion of the spin off of Myriad Pharmaceuticals, and that Myriad Genetics has received a Private Letter Ruling from the Internal Revenue Service.
  Myriad Genetics, Inc. July 01, 2009  
• ARCA biopharma announces changes to management team  ARCA biopharma announced changes to its management team to reflect the Company's recent change in commercial strategy to seek alternatives for the potential commercialization of Gencaro.
  ARCA biopharma, Inc. July 01, 2009  
• FDA: Boxed warning on serious mental health events to be required for Chantix and Zyban  The U.S. Food and Drug Administration announced that it is requiring manufacturers to put a Boxed Warning on the prescribing information for the smoking cessation drugs Chantix (varenicline) and Zyban (bupropion).
  FDA July 01, 2009  
• Pfizer updates CHANTIX (R) (varenicline) labeling in the United States  Pfizer announced that it has updated the U.S. product labeling for CHANTIX(R) (varenicline), a prescription aid to smoking cessation treatment, to communicate important safety information in a boxed warning as well as in revised warnings and precautions.
  Pfizer Inc. July 01, 2009  
• Pfizer launches medicine assistance program for newly unemployed  An assistance program offered by Pfizer that can help unemployed Americans continue receiving their prescription medicines. The program is fully operational July 1.
  Pfizer Inc. July 01, 2009  

   (next 10 articles)